Literature DB >> 12617574

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

Henry Masur1, Jonathan E Kaplan, King K Holmes.   

Abstract

In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV); these guidelines were updated in 1997 and 1999. This fourth edition of the guidelines, made available on the Internet in 2001, is intended for clinicians and other health-care providers who care for HIV-infected persons. The goal of these guidelines is to provide evidence-based guidelines for preventing OIs among HIV-infected adults and adolescents, including pregnant women, and HIV-exposed or infected children. Nineteen OIs, or groups of OIs, are addressed, and recommendations are included for preventing exposure to opportunistic pathogens, preventing first episodes of disease by chemoprophylaxis or vaccination (primary prophylaxis), and preventing disease recurrence (secondary prophylaxis). Major changes since the last edition of the guidelines include 1) updated recommendations for discontinuing primary and secondary OI prophylaxis among persons whose CD4+ T lymphocyte counts have increased in response to antiretroviral therapy; 2) emphasis on screening all HIV-infected persons for infection with hepatitis C virus; 3) new information regarding transmission of human herpesvirus 8 infection; 4) new information regarding drug interactions, chiefly related to rifamycins and antiretroviral drugs; and 5) revised recommendations for immunizing HIV-infected adults and adolescents and HIV-exposed or infected children.

Entities:  

Mesh:

Year:  2002        PMID: 12617574     DOI: 10.7326/0003-4819-137-5_part_2-200209031-00002

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  44 in total

Review 1.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

2.  Bartonella henselae endocarditis in a child.

Authors:  Clovis W Pitchford; C Buddy Creech; Timothy R Peters; Cindy L Vnencak-Jones
Journal:  Pediatr Cardiol       Date:  2006-11-16       Impact factor: 1.655

3.  Update on Hepatitis B and C Coinfection in HIV.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

4.  Recommendations for the use of albumin and immunoglobulins.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossettias
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

Review 5.  [Tuberculosis-current therapeutic principles].

Authors:  U Greinert; P Zabel
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

Review 6.  Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors:  Martin Rodriguez; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.

Authors:  Bruce R Schackman; Callie A Scott; Paul E Sax; Elena Losina; Timothy J Wilkin; John E McKinnon; Susan Swindells; Milton C Weinstein; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2007-09-04       Impact factor: 9.079

8.  Risk of healthcare associated infections in HIV positive patients.

Authors:  Mohammed Mitha; E Yoko Furuya; Elaine Larson
Journal:  J Infect Prev       Date:  2014-11-01

9.  Cerebral Mycobacterium avium abscesses: Late immune reconstitution syndrome in an HIV-1-infected patient receiving highly active antiretroviral therapy.

Authors:  Claude Fortin; Danielle Rouleau
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

10.  Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

Authors:  Richard G Lalonde; Guy Boivin; Jean Deschênes; William G Hodge; J Jill Hopkins; Alex H Klein; Janette I Lindley; Peter Phillips; Stephen D Shafran; Sharon Walmsley
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.